Survival impact of pathologic features after salvage lung resection following definitive chemoradiotherapy or systemic therapy for initially unresectable lung cancer
General Thoracic and Cardiovascular Surgery · 2025
DOI: 10.1007/s11748-024-02086-y ↗Kurz gefasst
Fachartikel in der Zeitschrift General Thoracic and Cardiovascular Surgery, 2025. Verfasst von Naoyuki Oka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Salvage Therapy, Pneumonectomy, Chemoradiotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Salvage surgery for primary lung cancer is expected to become increasingly common. This study aimed to clarify the survival impact of pathologic characteristics after salvage surgery. METHODS: Consecutive patients who underwent salvage surgery following definitive chemoradiotherapy or systemic therapy for initially unresectable lung cancer from 2010 to 2020 were enrolled in this study. The tumor slides were reviewed to determine the size of the tumor bed and the proportions of viable tumor, necrosis, and stroma. RESULTS: A total of 23 patients were evaluated, and 18 had clinical stage IIIB-IV disease. Six received chemoradiotherapy and 17 received systemic therapy alone. A major pathologic response (MPR, ≤ 10% of viable tumor) was observed in 6 patients, and 4 patients achieved a pathological complete response. The 3-year overall and recurrence-free survival rates (OS and RFS) were 78.6% and 59.2%, respectively. There was no significant difference in OS between patients with and without MPR, and even non-MPR patients achieved a favorable 3-year OS of 70.2%. Meanwhile, patients with high (≥ 30%) stroma showed significantly better OS than those with low (< 30%) stroma (3-year OS: 100% vs. 23.3%, p < 0.001). CONCLUSIONS: This study showed that the proportion of stroma can be useful for predicting long-term survival after salvage surgery. Further large-scale studies are warranted to confirm the current findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Thoracic Surgery, Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
- Division of Thoracic Surgery, Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. thishida@nifty.com.
- Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
Zitieren
APA
Oka, N., Hishida, T., Kaseda, K., Suzuki, Y., Okubo, Y., Masai, K., Asakura, K., Emoto, K., & Asamura, H. (2025). Survival impact of pathologic features after salvage lung resection following definitive chemoradiotherapy or systemic therapy for initially unresectable lung cancer. General Thoracic and Cardiovascular Surgery. https://doi.org/10.1007/s11748-024-02086-y
Vancouver
Oka N, Hishida T, Kaseda K, Suzuki Y, Okubo Y, Masai K, et al. Survival impact of pathologic features after salvage lung resection following definitive chemoradiotherapy or systemic therapy for initially unresectable lung cancer. General Thoracic and Cardiovascular Surgery. 2025. doi:10.1007/s11748-024-02086-y
BibTeX
@article{Oka2025,
author = {Oka, Naoyuki and Hishida, Tomoyuki and Kaseda, Kaoru and Suzuki, Yuri and Okubo, Yu and Masai, Kyohei and Asakura, Keisuke and Emoto, Katsura and Asamura, Hisao},
title = {Survival impact of pathologic features after salvage lung resection following definitive chemoradiotherapy or systemic therapy for initially unresectable lung cancer},
journal = {General Thoracic and Cardiovascular Surgery},
year = {2025},
doi = {10.1007/s11748-024-02086-y}
}
EUVIMED